HepQuant SHUNT is Superior to Child-Pugh in Defining Hepatic Impairment for Pharmacokinetic Studies: Experience with Ampreloxetine (An Encore Presentation)

HepQuant SHUNT is Superior to Child-Pugh in Defining Hepatic Impairment for Pharmacokinetic Studies: Experience with Ampreloxetine (An Encore Presentation)

August 2022

Source: Hepatology 2022; AASLD accepted poster presentation.

Publication: